CSL share price rises after RBC upgrade, with Feb results now the next test
CSL shares closed up 0.55% at A$176.50 Monday after RBC Capital Markets upgraded the stock, defying a weaker S&P/ASX 200. RBC warned of a tough earnings season for healthcare, with most results likely to miss expectations. Investors now await Australia’s jobs data on Jan. 22 and CSL’s half-year results due Feb. 11. No new company filings were posted Monday.